Isn't Bthcf trying to identify 17 different medical diseases? Each one having its own protocols to prove out...my point is...that's a lot more hurdles than Blozf having only the thc hurdle. I own a lot of both stocks, but realistically think Blozf will hit pay dirt first. Both stocks are undervalued and I am long in both.
Breathtec’s entry into a licensing agreement will further investigation and advance development of NA-NOSE disease detection capabilities for the detection of the following indications from exhaled breath: Streptococcus; Methicillin resistant (MRSA); Staphylococcus; Enterococcus; Vancomycin resistant (VRE); Pneumococcus; Hemophilus influenza (HiB); Chickenpox; and the common cold. The testing of the novel ‘NA-NOSE’ prototypes will be carried out in three separate trials: